Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zajecka

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Brain Stimulation|December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trialA John Rush, Charles R Conway, Scott T Aaronson, et al.
Brain Stimulation|December 20, 2024
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trialCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
The International Journal of Neuropsychopharmacology|January 13, 2026
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial reportCharles R Conway, Augustus John Rush, Scott T Aaronson, et al.
Neuropsychiatric Disease and Treatment|March 26, 2026
The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus StatementR Hamish McAllister-Williams, Gustavo Alva, Michael Banov, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Brain Stimulation|December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trialA John Rush, Charles R Conway, Scott T Aaronson, et al.
Brain Stimulation|December 20, 2024
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trialCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
The International Journal of Neuropsychopharmacology|January 13, 2026
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial reportCharles R Conway, Augustus John Rush, Scott T Aaronson, et al.
Neuropsychiatric Disease and Treatment|March 26, 2026
The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus StatementR Hamish McAllister-Williams, Gustavo Alva, Michael Banov, et al.
Pageof 4